Boston Scientific has extended its contract with a provider of holmium laser technology, Lumenis.
Under the five-year extending agreement, Boston will remain as the US distributor for Lumenis’ holmium laser fibers.
Holmium laser fibers are designed for use with surgical lasers to treat a variety of urologic conditions.
Boston Scientific medSurg division executive vice president and president Michael Phalen said the company look forward to continue to provide urologists with clinically beneficial technologies that improve patient care.